BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moreno JA, Hamza E, Guerrero-Hue M, Rayego-Mateos S, García-Caballero C, Vallejo-Mudarra M, Metzinger L, Metzinger-Le Meuth V. Non-Coding RNAs in Kidney Diseases: The Long and Short of Them. Int J Mol Sci 2021;22:6077. [PMID: 34199920 DOI: 10.3390/ijms22116077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Grobe N, Scheiber J, Zhang H, Garbe C, Wang X. Omics and Artificial Intelligence in Kidney Diseases. Adv Kidney Dis Health 2023;30:47-52. [PMID: 36723282 DOI: 10.1053/j.akdh.2022.11.005] [Reference Citation Analysis]
2 Kong AS, Lai KS, Lim SE, Sivalingam S, Loh JY, Maran S. miRNA in Ischemic Heart Disease and Its Potential as Biomarkers: A Comprehensive Review. Int J Mol Sci 2022;23:9001. [PMID: 36012267 DOI: 10.3390/ijms23169001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hill C, Avila-palencia I, Maxwell AP, Hunter RF, Mcknight AJ. Harnessing the Full Potential of Multi-Omic Analyses to Advance the Study and Treatment of Chronic Kidney Disease. Front Nephrol 2022;2. [DOI: 10.3389/fneph.2022.923068] [Reference Citation Analysis]
4 Metzinger L, Moreno JA, Metzinger-Le Meuth V. The Role of Non-Coding RNAs in Kidney Diseases. Int J Mol Sci 2022;23:6624. [PMID: 35743064 DOI: 10.3390/ijms23126624] [Reference Citation Analysis]
5 Riffo-Campos AL, Perez-Hernandez J, Ortega A, Martinez-Arroyo O, Flores-Chova A, Redon J, Cortes R. Exosomal and Plasma Non-Coding RNA Signature Associated with Urinary Albumin Excretion in Hypertension. Int J Mol Sci 2022;23:823. [PMID: 35055008 DOI: 10.3390/ijms23020823] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Li Y, Tan Y, Zhang R, Wang T, Na N, Zheng T, Veedu RN, Chen S. Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease. Kidney and Dialysis 2022;2:16-37. [DOI: 10.3390/kidneydial2010004] [Reference Citation Analysis]
7 Winiarska A, Knysak M, Nabrdalik K, Gumprecht J, Stompór T. Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists. Int J Mol Sci 2021;22:10822. [PMID: 34639160 DOI: 10.3390/ijms221910822] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
8 Fourdinier O, Glorieux G, Brigant B, Diouf M, Pletinck A, Vanholder R, Choukroun G, Verbeke F, Massy ZA, Metzinger-Le Meuth V, Metzinger L, Group-EUTox OBOTEUTW. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease. Int J Mol Sci 2021;22:10549. [PMID: 34638892 DOI: 10.3390/ijms221910549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tracz J, Luczak M. Applying Proteomics and Integrative "Omics" Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis. Int J Mol Sci 2021;22:7492. [PMID: 34299112 DOI: 10.3390/ijms22147492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]